Global Covid-19 Treatment Market Strategic Research Report

Scope of the Report

Patients today have more treatment options in the battle against coronavirus disease.

In November 2020, the FDA granted emergency use authorization to two monoclonal antibody treatments (bamlanivimab, made by Eli Lilly; and a combination of casirivimab and imdevimab, made by Regeneron). Both treatments have been approved for non-hospitalized adults and children over age 12 with mild to moderate COVID-19 symptoms who are at risk for developing severe COVID-19 or being hospitalized for it. In these patients, the approved treatments can reduce the risk of hospitalization and emergency room visits. These therapies must be given intravenously (by IV) soon after developing symptoms.

The FDA has approved the antiviral drug Veklury (remdesivir) for adults and certain pediatric patients with COVID-19 who are sick enough to need hospitalization. Veklury should only be administered in a hospital or in a health care setting capable of providing acute care comparable to inpatient hospital care.

The Drugs for Covid-19: Dexamethasone, Tocilizumab, Remdesivir, Baricitinib in combination with remdesivir, Anticoagulation drugs ("blood thinners"), etc.

In August 2020, the FDA issued an emergency use authorization (EUA) for convalescent plasma in patients hospitalized with COVID-19.

In this report, we study all treatment method for Covid-19.

Global core covid-19 treatment manufacturers include Cadila Healthcare, Novartis etc.The top 2 companies hold a share about 30%.North America is the largest market, with a share about 47%, followed by Europe and Asia Pacific with the share about 30% and 9%.

This report presents a comprehensive overview of the global Covid-19 Treatment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Life Support
• Antiviral Medicine
• Antibody Treatments
• Others

Segment by players, this report covers

• Cadila Healthcare
• Johnson & Johnson
• ImmunoPrecise
• Novartis
• AstraZeneca
• Cipla
• AbbVie
• Bayer
• Regeneron Pharmaceuticals
• Ascletis Pharma
• GlaxoSmithKline
• Gilead Sciences
• Pharmstandard
• Fujifilm Holdings
• Zhejiang Hisun Pharmaceutical Co. Ltd
• Roche
• Sanofi
• Pfizer
• Eli Lilly

Segment by Application

• Children
• Adult

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Covid-19 Treatment market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Children, Adult evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact